nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—ovarian cancer	0.285	1	CbGaD
Boceprevir—ABCB1—Topotecan—ovarian cancer	0.0438	0.172	CbGbCtD
Boceprevir—CYP3A5—Paclitaxel—ovarian cancer	0.0333	0.131	CbGbCtD
Boceprevir—ABCB1—Vinorelbine—ovarian cancer	0.0308	0.121	CbGbCtD
Boceprevir—CYP3A4—Topotecan—ovarian cancer	0.0262	0.103	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—ovarian cancer	0.0241	0.0944	CbGbCtD
Boceprevir—ABCB1—Paclitaxel—ovarian cancer	0.0217	0.0849	CbGbCtD
Boceprevir—CYP3A4—Vinorelbine—ovarian cancer	0.0185	0.0724	CbGbCtD
Boceprevir—ABCB1—Docetaxel—ovarian cancer	0.0157	0.0614	CbGbCtD
Boceprevir—CYP3A4—Paclitaxel—ovarian cancer	0.013	0.0509	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—ovarian cancer	0.0117	0.0458	CbGbCtD
Boceprevir—CYP3A4—Docetaxel—ovarian cancer	0.00939	0.0368	CbGbCtD
Boceprevir—CYP3A4—Doxorubicin—ovarian cancer	0.007	0.0274	CbGbCtD
Boceprevir—CTSV—myometrium—ovarian cancer	0.00519	0.0393	CbGeAlD
Boceprevir—CTSL—myometrium—ovarian cancer	0.00424	0.0321	CbGeAlD
Boceprevir—CTSL—embryo—ovarian cancer	0.00408	0.0308	CbGeAlD
Boceprevir—CTSV—uterine cervix—ovarian cancer	0.00404	0.0306	CbGeAlD
Boceprevir—CTSV—decidua—ovarian cancer	0.00385	0.0291	CbGeAlD
Boceprevir—CTSV—endometrium—ovarian cancer	0.00365	0.0276	CbGeAlD
Boceprevir—CTSV—gonad—ovarian cancer	0.00339	0.0256	CbGeAlD
Boceprevir—CTSL—epithelium—ovarian cancer	0.00333	0.0252	CbGeAlD
Boceprevir—CTSL—uterine cervix—ovarian cancer	0.0033	0.025	CbGeAlD
Boceprevir—CTSK—myometrium—ovarian cancer	0.00319	0.0242	CbGeAlD
Boceprevir—CTSL—decidua—ovarian cancer	0.00314	0.0238	CbGeAlD
Boceprevir—CTSV—female reproductive system—ovarian cancer	0.00303	0.0229	CbGeAlD
Boceprevir—CTSL—endometrium—ovarian cancer	0.00298	0.0226	CbGeAlD
Boceprevir—CMA1—female reproductive system—ovarian cancer	0.00289	0.0219	CbGeAlD
Boceprevir—CTSS—myometrium—ovarian cancer	0.0028	0.0212	CbGeAlD
Boceprevir—CTSL—gonad—ovarian cancer	0.00277	0.0209	CbGeAlD
Boceprevir—CTSV—female gonad—ovarian cancer	0.00275	0.0208	CbGeAlD
Boceprevir—CTSL—uterus—ovarian cancer	0.00275	0.0208	CbGeAlD
Boceprevir—CTSV—vagina—ovarian cancer	0.00274	0.0207	CbGeAlD
Boceprevir—CMA1—bone marrow—ovarian cancer	0.00273	0.0206	CbGeAlD
Boceprevir—CTSS—embryo—ovarian cancer	0.00269	0.0204	CbGeAlD
Boceprevir—CTSK—uterine cervix—ovarian cancer	0.00249	0.0188	CbGeAlD
Boceprevir—CTSL—female reproductive system—ovarian cancer	0.00247	0.0187	CbGeAlD
Boceprevir—CTSV—testis—ovarian cancer	0.00244	0.0185	CbGeAlD
Boceprevir—CTSK—decidua—ovarian cancer	0.00237	0.0179	CbGeAlD
Boceprevir—CTSL—bone marrow—ovarian cancer	0.00233	0.0177	CbGeAlD
Boceprevir—CTSL—female gonad—ovarian cancer	0.00225	0.017	CbGeAlD
Boceprevir—CTSK—endometrium—ovarian cancer	0.00225	0.017	CbGeAlD
Boceprevir—CTSL—vagina—ovarian cancer	0.00224	0.0169	CbGeAlD
Boceprevir—CTSS—uterine cervix—ovarian cancer	0.00218	0.0165	CbGeAlD
Boceprevir—CTSK—gonad—ovarian cancer	0.00209	0.0158	CbGeAlD
Boceprevir—CTSS—decidua—ovarian cancer	0.00208	0.0157	CbGeAlD
Boceprevir—CTSK—uterus—ovarian cancer	0.00207	0.0157	CbGeAlD
Boceprevir—Telaprevir—ABCB1—ovarian cancer	0.00202	1	CrCbGaD
Boceprevir—CTSL—testis—ovarian cancer	0.002	0.0151	CbGeAlD
Boceprevir—CTSS—endometrium—ovarian cancer	0.00197	0.0149	CbGeAlD
Boceprevir—CTSK—female reproductive system—ovarian cancer	0.00186	0.0141	CbGeAlD
Boceprevir—CTSS—gonad—ovarian cancer	0.00183	0.0138	CbGeAlD
Boceprevir—CTSS—uterus—ovarian cancer	0.00182	0.0137	CbGeAlD
Boceprevir—CTSK—bone marrow—ovarian cancer	0.00176	0.0133	CbGeAlD
Boceprevir—CTSK—female gonad—ovarian cancer	0.00169	0.0128	CbGeAlD
Boceprevir—CMA1—lymph node—ovarian cancer	0.00169	0.0128	CbGeAlD
Boceprevir—CTSK—vagina—ovarian cancer	0.00168	0.0127	CbGeAlD
Boceprevir—CTSS—female reproductive system—ovarian cancer	0.00163	0.0123	CbGeAlD
Boceprevir—CTSS—bone marrow—ovarian cancer	0.00154	0.0117	CbGeAlD
Boceprevir—CTSK—testis—ovarian cancer	0.0015	0.0114	CbGeAlD
Boceprevir—CTSS—female gonad—ovarian cancer	0.00149	0.0112	CbGeAlD
Boceprevir—CTSS—vagina—ovarian cancer	0.00148	0.0112	CbGeAlD
Boceprevir—CTSL—lymph node—ovarian cancer	0.00145	0.0109	CbGeAlD
Boceprevir—CTSS—testis—ovarian cancer	0.00132	0.00996	CbGeAlD
Boceprevir—CTSK—lymph node—ovarian cancer	0.00109	0.00824	CbGeAlD
Boceprevir—CTSS—lymph node—ovarian cancer	0.000955	0.00722	CbGeAlD
Boceprevir—CYP3A5—uterine cervix—ovarian cancer	0.000723	0.00547	CbGeAlD
Boceprevir—ABCB1—myometrium—ovarian cancer	0.000494	0.00373	CbGeAlD
Boceprevir—CYP3A5—female gonad—ovarian cancer	0.000493	0.00373	CbGeAlD
Boceprevir—CYP3A5—vagina—ovarian cancer	0.00049	0.00371	CbGeAlD
Boceprevir—ABCB1—embryo—ovarian cancer	0.000475	0.00359	CbGeAlD
Boceprevir—CYP3A4—female reproductive system—ovarian cancer	0.000407	0.00308	CbGeAlD
Boceprevir—ABCB1—epithelium—ovarian cancer	0.000388	0.00293	CbGeAlD
Boceprevir—ABCB1—uterine cervix—ovarian cancer	0.000384	0.00291	CbGeAlD
Boceprevir—ABCB1—decidua—ovarian cancer	0.000366	0.00277	CbGeAlD
Boceprevir—ABCB1—endometrium—ovarian cancer	0.000348	0.00263	CbGeAlD
Boceprevir—ABCB1—gonad—ovarian cancer	0.000322	0.00244	CbGeAlD
Boceprevir—ABCB1—uterus—ovarian cancer	0.00032	0.00242	CbGeAlD
Boceprevir—ABCB1—female reproductive system—ovarian cancer	0.000288	0.00218	CbGeAlD
Boceprevir—ABCB1—bone marrow—ovarian cancer	0.000272	0.00206	CbGeAlD
Boceprevir—ABCB1—female gonad—ovarian cancer	0.000262	0.00198	CbGeAlD
Boceprevir—ABCB1—vagina—ovarian cancer	0.00026	0.00197	CbGeAlD
Boceprevir—ABCB1—testis—ovarian cancer	0.000232	0.00176	CbGeAlD
Boceprevir—ABCB1—lymph node—ovarian cancer	0.000168	0.00127	CbGeAlD
Boceprevir—Hypertension—Docetaxel—ovarian cancer	0.000116	0.000522	CcSEcCtD
Boceprevir—Infestation—Epirubicin—ovarian cancer	0.000116	0.000522	CcSEcCtD
Boceprevir—Infestation NOS—Epirubicin—ovarian cancer	0.000116	0.000522	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—ovarian cancer	0.000115	0.000521	CcSEcCtD
Boceprevir—Dyspnoea—Paclitaxel—ovarian cancer	0.000115	0.000519	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000115	0.000517	CcSEcCtD
Boceprevir—Arthralgia—Docetaxel—ovarian cancer	0.000114	0.000515	CcSEcCtD
Boceprevir—Myalgia—Docetaxel—ovarian cancer	0.000114	0.000515	CcSEcCtD
Boceprevir—Chest pain—Docetaxel—ovarian cancer	0.000114	0.000515	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—ovarian cancer	0.000114	0.000514	CcSEcCtD
Boceprevir—Nausea—Vinorelbine—ovarian cancer	0.000114	0.000514	CcSEcCtD
Boceprevir—Dyspepsia—Paclitaxel—ovarian cancer	0.000114	0.000512	CcSEcCtD
Boceprevir—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000113	0.000511	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000113	0.000511	CcSEcCtD
Boceprevir—Stomatitis—Epirubicin—ovarian cancer	0.000113	0.000509	CcSEcCtD
Boceprevir—Conjunctivitis—Epirubicin—ovarian cancer	0.000112	0.000507	CcSEcCtD
Boceprevir—Urinary tract infection—Epirubicin—ovarian cancer	0.000112	0.000507	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—ovarian cancer	0.000112	0.000506	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—ovarian cancer	0.000112	0.000506	CcSEcCtD
Boceprevir—Decreased appetite—Paclitaxel—ovarian cancer	0.000112	0.000506	CcSEcCtD
Boceprevir—Dry mouth—Docetaxel—ovarian cancer	0.000112	0.000503	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000111	0.000502	CcSEcCtD
Boceprevir—Fatigue—Paclitaxel—ovarian cancer	0.000111	0.000502	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—ovarian cancer	0.000111	0.0005	CcSEcCtD
Boceprevir—Constipation—Paclitaxel—ovarian cancer	0.00011	0.000498	CcSEcCtD
Boceprevir—Pain—Paclitaxel—ovarian cancer	0.00011	0.000498	CcSEcCtD
Boceprevir—Confusional state—Docetaxel—ovarian cancer	0.00011	0.000497	CcSEcCtD
Boceprevir—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00011	0.000494	CcSEcCtD
Boceprevir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000109	0.000493	CcSEcCtD
Boceprevir—Epistaxis—Epirubicin—ovarian cancer	0.000109	0.000492	CcSEcCtD
Boceprevir—Infection—Docetaxel—ovarian cancer	0.000109	0.00049	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—ovarian cancer	0.000109	0.00049	CcSEcCtD
Boceprevir—Sinusitis—Epirubicin—ovarian cancer	0.000108	0.000489	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000108	0.000488	CcSEcCtD
Boceprevir—Agranulocytosis—Epirubicin—ovarian cancer	0.000108	0.000487	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—ovarian cancer	0.000108	0.000486	CcSEcCtD
Boceprevir—Shock—Docetaxel—ovarian cancer	0.000108	0.000485	CcSEcCtD
Boceprevir—Nervous system disorder—Docetaxel—ovarian cancer	0.000107	0.000484	CcSEcCtD
Boceprevir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000107	0.000483	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—ovarian cancer	0.000107	0.000483	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—ovarian cancer	0.000107	0.000483	CcSEcCtD
Boceprevir—Tachycardia—Docetaxel—ovarian cancer	0.000107	0.000481	CcSEcCtD
Boceprevir—Feeling abnormal—Paclitaxel—ovarian cancer	0.000106	0.00048	CcSEcCtD
Boceprevir—Skin disorder—Docetaxel—ovarian cancer	0.000106	0.000479	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000106	0.000479	CcSEcCtD
Boceprevir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000105	0.000476	CcSEcCtD
Boceprevir—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000105	0.000473	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—ovarian cancer	0.000104	0.000471	CcSEcCtD
Boceprevir—Rhinitis—Epirubicin—ovarian cancer	0.000104	0.00047	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—ovarian cancer	0.000104	0.000469	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—ovarian cancer	0.000104	0.000469	CcSEcCtD
Boceprevir—Hypoaesthesia—Epirubicin—ovarian cancer	0.000103	0.000466	CcSEcCtD
Boceprevir—Pharyngitis—Epirubicin—ovarian cancer	0.000103	0.000465	CcSEcCtD
Boceprevir—Urinary tract disorder—Epirubicin—ovarian cancer	0.000102	0.000463	CcSEcCtD
Boceprevir—Urticaria—Paclitaxel—ovarian cancer	0.000102	0.000462	CcSEcCtD
Boceprevir—Oedema peripheral—Epirubicin—ovarian cancer	0.000102	0.000461	CcSEcCtD
Boceprevir—Hypotension—Docetaxel—ovarian cancer	0.000102	0.000461	CcSEcCtD
Boceprevir—Connective tissue disorder—Epirubicin—ovarian cancer	0.000102	0.00046	CcSEcCtD
Boceprevir—Abdominal pain—Paclitaxel—ovarian cancer	0.000102	0.00046	CcSEcCtD
Boceprevir—Body temperature increased—Paclitaxel—ovarian cancer	0.000102	0.00046	CcSEcCtD
Boceprevir—Urethral disorder—Epirubicin—ovarian cancer	0.000102	0.000459	CcSEcCtD
Boceprevir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000101	0.000457	CcSEcCtD
Boceprevir—Epistaxis—Doxorubicin—ovarian cancer	0.000101	0.000455	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—ovarian cancer	0.0001	0.000453	CcSEcCtD
Boceprevir—Visual impairment—Epirubicin—ovarian cancer	0.0001	0.000451	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—ovarian cancer	9.98e-05	0.00045	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9.96e-05	0.000449	CcSEcCtD
Boceprevir—Insomnia—Docetaxel—ovarian cancer	9.89e-05	0.000446	CcSEcCtD
Boceprevir—Paraesthesia—Docetaxel—ovarian cancer	9.82e-05	0.000443	CcSEcCtD
Boceprevir—Erythema multiforme—Epirubicin—ovarian cancer	9.81e-05	0.000443	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—ovarian cancer	9.75e-05	0.00044	CcSEcCtD
Boceprevir—Eye disorder—Epirubicin—ovarian cancer	9.7e-05	0.000438	CcSEcCtD
Boceprevir—Tinnitus—Epirubicin—ovarian cancer	9.68e-05	0.000437	CcSEcCtD
Boceprevir—Flushing—Epirubicin—ovarian cancer	9.63e-05	0.000435	CcSEcCtD
Boceprevir—Cardiac disorder—Epirubicin—ovarian cancer	9.63e-05	0.000435	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—ovarian cancer	9.63e-05	0.000434	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—ovarian cancer	9.62e-05	0.000434	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—ovarian cancer	9.56e-05	0.000431	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—ovarian cancer	9.53e-05	0.00043	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—ovarian cancer	9.5e-05	0.000429	CcSEcCtD
Boceprevir—Hypersensitivity—Paclitaxel—ovarian cancer	9.5e-05	0.000429	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—ovarian cancer	9.48e-05	0.000428	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—ovarian cancer	9.46e-05	0.000427	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.44e-05	0.000426	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—ovarian cancer	9.44e-05	0.000426	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—ovarian cancer	9.43e-05	0.000425	CcSEcCtD
Boceprevir—Angiopathy—Epirubicin—ovarian cancer	9.42e-05	0.000425	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—ovarian cancer	9.41e-05	0.000425	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—ovarian cancer	9.37e-05	0.000423	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—ovarian cancer	9.35e-05	0.000422	CcSEcCtD
Boceprevir—Pain—Docetaxel—ovarian cancer	9.35e-05	0.000422	CcSEcCtD
Boceprevir—Constipation—Docetaxel—ovarian cancer	9.35e-05	0.000422	CcSEcCtD
Boceprevir—Chills—Epirubicin—ovarian cancer	9.31e-05	0.00042	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—ovarian cancer	9.27e-05	0.000418	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—ovarian cancer	9.25e-05	0.000418	CcSEcCtD
Boceprevir—Asthenia—Paclitaxel—ovarian cancer	9.25e-05	0.000418	CcSEcCtD
Boceprevir—Alopecia—Epirubicin—ovarian cancer	9.17e-05	0.000414	CcSEcCtD
Boceprevir—Pruritus—Paclitaxel—ovarian cancer	9.13e-05	0.000412	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—ovarian cancer	9.09e-05	0.00041	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—ovarian cancer	9.08e-05	0.00041	CcSEcCtD
Boceprevir—Erythema—Epirubicin—ovarian cancer	9.03e-05	0.000408	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—ovarian cancer	9.03e-05	0.000408	CcSEcCtD
Boceprevir—Feeling abnormal—Docetaxel—ovarian cancer	9.01e-05	0.000407	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—ovarian cancer	8.97e-05	0.000405	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—ovarian cancer	8.95e-05	0.000404	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—ovarian cancer	8.94e-05	0.000403	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—ovarian cancer	8.91e-05	0.000402	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—ovarian cancer	8.91e-05	0.000402	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—ovarian cancer	8.9e-05	0.000402	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—ovarian cancer	8.85e-05	0.000399	CcSEcCtD
Boceprevir—Diarrhoea—Paclitaxel—ovarian cancer	8.82e-05	0.000398	CcSEcCtD
Boceprevir—Back pain—Epirubicin—ovarian cancer	8.74e-05	0.000394	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—ovarian cancer	8.71e-05	0.000393	CcSEcCtD
Boceprevir—Muscle spasms—Epirubicin—ovarian cancer	8.69e-05	0.000392	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—ovarian cancer	8.67e-05	0.000391	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—ovarian cancer	8.65e-05	0.000391	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—ovarian cancer	8.64e-05	0.00039	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—ovarian cancer	8.64e-05	0.00039	CcSEcCtD
Boceprevir—Chills—Doxorubicin—ovarian cancer	8.62e-05	0.000389	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—ovarian cancer	8.58e-05	0.000387	CcSEcCtD
Boceprevir—Dizziness—Paclitaxel—ovarian cancer	8.53e-05	0.000385	CcSEcCtD
Boceprevir—Vision blurred—Epirubicin—ovarian cancer	8.51e-05	0.000384	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—ovarian cancer	8.49e-05	0.000383	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—ovarian cancer	8.41e-05	0.00038	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—ovarian cancer	8.38e-05	0.000378	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—ovarian cancer	8.36e-05	0.000377	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—ovarian cancer	8.36e-05	0.000377	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—ovarian cancer	8.35e-05	0.000377	CcSEcCtD
Boceprevir—Agitation—Epirubicin—ovarian cancer	8.3e-05	0.000375	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—ovarian cancer	8.24e-05	0.000372	CcSEcCtD
Boceprevir—Vomiting—Paclitaxel—ovarian cancer	8.2e-05	0.00037	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—ovarian cancer	8.19e-05	0.000369	CcSEcCtD
Boceprevir—Malaise—Epirubicin—ovarian cancer	8.15e-05	0.000368	CcSEcCtD
Boceprevir—Rash—Paclitaxel—ovarian cancer	8.13e-05	0.000367	CcSEcCtD
Boceprevir—Dermatitis—Paclitaxel—ovarian cancer	8.12e-05	0.000367	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—ovarian cancer	8.12e-05	0.000366	CcSEcCtD
Boceprevir—Syncope—Epirubicin—ovarian cancer	8.1e-05	0.000366	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—ovarian cancer	8.09e-05	0.000365	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—ovarian cancer	8.09e-05	0.000365	CcSEcCtD
Boceprevir—Headache—Paclitaxel—ovarian cancer	8.08e-05	0.000365	CcSEcCtD
Boceprevir—Hypersensitivity—Docetaxel—ovarian cancer	8.05e-05	0.000363	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—ovarian cancer	8.04e-05	0.000363	CcSEcCtD
Boceprevir—Palpitations—Epirubicin—ovarian cancer	7.98e-05	0.00036	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—ovarian cancer	7.94e-05	0.000358	CcSEcCtD
Boceprevir—Cough—Epirubicin—ovarian cancer	7.88e-05	0.000356	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—ovarian cancer	7.88e-05	0.000356	CcSEcCtD
Boceprevir—Asthenia—Docetaxel—ovarian cancer	7.84e-05	0.000354	CcSEcCtD
Boceprevir—Hypertension—Epirubicin—ovarian cancer	7.8e-05	0.000352	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—ovarian cancer	7.76e-05	0.00035	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—ovarian cancer	7.73e-05	0.000349	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—ovarian cancer	7.73e-05	0.000349	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—ovarian cancer	7.69e-05	0.000347	CcSEcCtD
Boceprevir—Chest pain—Epirubicin—ovarian cancer	7.69e-05	0.000347	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—ovarian cancer	7.69e-05	0.000347	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—ovarian cancer	7.68e-05	0.000347	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—ovarian cancer	7.67e-05	0.000346	CcSEcCtD
Boceprevir—Nausea—Paclitaxel—ovarian cancer	7.66e-05	0.000346	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.64e-05	0.000345	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—ovarian cancer	7.6e-05	0.000343	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—ovarian cancer	7.54e-05	0.00034	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—ovarian cancer	7.52e-05	0.000339	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—ovarian cancer	7.51e-05	0.000339	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—ovarian cancer	7.5e-05	0.000338	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—ovarian cancer	7.48e-05	0.000338	CcSEcCtD
Boceprevir—Diarrhoea—Docetaxel—ovarian cancer	7.48e-05	0.000338	CcSEcCtD
Boceprevir—Confusional state—Epirubicin—ovarian cancer	7.43e-05	0.000336	CcSEcCtD
Boceprevir—Palpitations—Doxorubicin—ovarian cancer	7.39e-05	0.000333	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—ovarian cancer	7.35e-05	0.000332	CcSEcCtD
Boceprevir—Infection—Epirubicin—ovarian cancer	7.33e-05	0.000331	CcSEcCtD
Boceprevir—Cough—Doxorubicin—ovarian cancer	7.29e-05	0.000329	CcSEcCtD
Boceprevir—Shock—Epirubicin—ovarian cancer	7.25e-05	0.000327	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—ovarian cancer	7.23e-05	0.000326	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—ovarian cancer	7.23e-05	0.000326	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—ovarian cancer	7.22e-05	0.000326	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—ovarian cancer	7.22e-05	0.000326	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—ovarian cancer	7.2e-05	0.000325	CcSEcCtD
Boceprevir—Skin disorder—Epirubicin—ovarian cancer	7.16e-05	0.000323	CcSEcCtD
Boceprevir—Hyperhidrosis—Epirubicin—ovarian cancer	7.13e-05	0.000322	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—ovarian cancer	7.12e-05	0.000321	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—ovarian cancer	7.12e-05	0.000321	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—ovarian cancer	7.12e-05	0.000321	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—ovarian cancer	7.09e-05	0.00032	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	7.07e-05	0.000319	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—ovarian cancer	7.03e-05	0.000317	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PIK3CB—ovarian cancer	6.96e-05	0.000672	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—MTOR—ovarian cancer	6.96e-05	0.000672	CbGpPWpGaD
Boceprevir—Dry mouth—Doxorubicin—ovarian cancer	6.96e-05	0.000314	CcSEcCtD
Boceprevir—Vomiting—Docetaxel—ovarian cancer	6.95e-05	0.000314	CcSEcCtD
Boceprevir—Rash—Docetaxel—ovarian cancer	6.89e-05	0.000311	CcSEcCtD
Boceprevir—Hypotension—Epirubicin—ovarian cancer	6.89e-05	0.000311	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—ovarian cancer	6.89e-05	0.000311	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—ovarian cancer	6.88e-05	0.00031	CcSEcCtD
Boceprevir—Headache—Docetaxel—ovarian cancer	6.85e-05	0.000309	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CDKN1B—ovarian cancer	6.81e-05	0.000657	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NRAS—ovarian cancer	6.79e-05	0.000655	CbGpPWpGaD
Boceprevir—Infection—Doxorubicin—ovarian cancer	6.78e-05	0.000306	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—KRAS—ovarian cancer	6.77e-05	0.000654	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—ovarian cancer	6.77e-05	0.000654	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.72e-05	0.000303	CcSEcCtD
Boceprevir—Shock—Doxorubicin—ovarian cancer	6.71e-05	0.000303	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—ovarian cancer	6.69e-05	0.000302	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—ovarian cancer	6.68e-05	0.000301	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—ovarian cancer	6.67e-05	0.000301	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—ovarian cancer	6.66e-05	0.0003	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—ovarian cancer	6.63e-05	0.000299	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—ovarian cancer	6.62e-05	0.000299	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—ovarian cancer	6.6e-05	0.000298	CcSEcCtD
Boceprevir—Dyspnoea—Epirubicin—ovarian cancer	6.57e-05	0.000297	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CDKN1B—ovarian cancer	6.54e-05	0.000631	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NRAS—ovarian cancer	6.52e-05	0.000629	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK3—ovarian cancer	6.5e-05	0.000628	CbGpPWpGaD
Boceprevir—Nausea—Docetaxel—ovarian cancer	6.49e-05	0.000293	CcSEcCtD
Boceprevir—Dyspepsia—Epirubicin—ovarian cancer	6.49e-05	0.000293	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—PIK3CA—ovarian cancer	6.48e-05	0.000625	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PIK3CA—ovarian cancer	6.48e-05	0.000625	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CTNNB1—ovarian cancer	6.43e-05	0.000621	CbGpPWpGaD
Boceprevir—Decreased appetite—Epirubicin—ovarian cancer	6.41e-05	0.000289	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	6.39e-05	0.000616	CbGpPWpGaD
Boceprevir—Hypotension—Doxorubicin—ovarian cancer	6.38e-05	0.000288	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.37e-05	0.000287	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—ovarian cancer	6.36e-05	0.000287	CcSEcCtD
Boceprevir—Constipation—Epirubicin—ovarian cancer	6.31e-05	0.000285	CcSEcCtD
Boceprevir—Pain—Epirubicin—ovarian cancer	6.31e-05	0.000285	CcSEcCtD
Boceprevir—CTSL—Immune System—ERBB2—ovarian cancer	6.27e-05	0.000605	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—ovarian cancer	6.27e-05	0.000605	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—ovarian cancer	6.27e-05	0.000605	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—ovarian cancer	6.22e-05	0.0006	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—ovarian cancer	6.22e-05	0.0006	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.22e-05	0.000281	CcSEcCtD
Boceprevir—CTSL—Immune System—MTOR—ovarian cancer	6.19e-05	0.000597	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CB—ovarian cancer	6.19e-05	0.000597	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CB—ovarian cancer	6.19e-05	0.000597	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MTOR—ovarian cancer	6.19e-05	0.000597	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK1—ovarian cancer	6.19e-05	0.000597	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—ovarian cancer	6.19e-05	0.000597	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	6.17e-05	0.000596	CbGpPWpGaD
Boceprevir—Insomnia—Doxorubicin—ovarian cancer	6.17e-05	0.000278	CcSEcCtD
Boceprevir—CTSK—Immune System—CDH1—ovarian cancer	6.16e-05	0.000595	CbGpPWpGaD
Boceprevir—Paraesthesia—Doxorubicin—ovarian cancer	6.13e-05	0.000276	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—ovarian cancer	6.08e-05	0.000274	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—ovarian cancer	6.08e-05	0.000274	CcSEcCtD
Boceprevir—Gastrointestinal pain—Epirubicin—ovarian cancer	6.03e-05	0.000272	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PTEN—ovarian cancer	6.02e-05	0.000581	CbGpPWpGaD
Boceprevir—Dyspepsia—Doxorubicin—ovarian cancer	6.01e-05	0.000271	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—HRAS—ovarian cancer	5.99e-05	0.000579	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—ovarian cancer	5.99e-05	0.000579	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR4—ovarian cancer	5.98e-05	0.000578	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	5.98e-05	0.000577	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—ovarian cancer	5.94e-05	0.000573	CbGpPWpGaD
Boceprevir—Decreased appetite—Doxorubicin—ovarian cancer	5.93e-05	0.000268	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.89e-05	0.000266	CcSEcCtD
Boceprevir—CTSK—Immune System—PIK3CD—ovarian cancer	5.89e-05	0.000568	CbGpPWpGaD
Boceprevir—Fatigue—Doxorubicin—ovarian cancer	5.88e-05	0.000265	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—ovarian cancer	5.86e-05	0.000264	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KRAS—ovarian cancer	5.84e-05	0.000564	CbGpPWpGaD
Boceprevir—Constipation—Doxorubicin—ovarian cancer	5.83e-05	0.000263	CcSEcCtD
Boceprevir—Pain—Doxorubicin—ovarian cancer	5.83e-05	0.000263	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—ovarian cancer	5.83e-05	0.000263	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—ovarian cancer	5.83e-05	0.000263	CcSEcCtD
Boceprevir—CTSL—Immune System—CDKN1B—ovarian cancer	5.81e-05	0.000561	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDKN1B—ovarian cancer	5.81e-05	0.000561	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TERT—ovarian cancer	5.76e-05	0.000556	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—ovarian cancer	5.76e-05	0.000556	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—ovarian cancer	5.76e-05	0.000556	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—ovarian cancer	5.74e-05	0.000554	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—ovarian cancer	5.74e-05	0.000554	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6ST—ovarian cancer	5.74e-05	0.000554	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—ovarian cancer	5.69e-05	0.000549	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—ovarian cancer	5.69e-05	0.000549	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	5.64e-05	0.000544	CbGpPWpGaD
Boceprevir—Feeling abnormal—Doxorubicin—ovarian cancer	5.62e-05	0.000254	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KRAS—ovarian cancer	5.61e-05	0.000542	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NME2—ovarian cancer	5.59e-05	0.00054	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—ovarian cancer	5.59e-05	0.00054	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.58e-05	0.000252	CcSEcCtD
Boceprevir—CTSV—Immune System—CTNNB1—ovarian cancer	5.49e-05	0.00053	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—ovarian cancer	5.49e-05	0.00053	CbGpPWpGaD
Boceprevir—Hypersensitivity—Epirubicin—ovarian cancer	5.43e-05	0.000245	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—ovarian cancer	5.42e-05	0.000245	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	5.41e-05	0.000522	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.4e-05	0.000521	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—ovarian cancer	5.4e-05	0.000521	CbGpPWpGaD
Boceprevir—Body temperature increased—Doxorubicin—ovarian cancer	5.39e-05	0.000243	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—ovarian cancer	5.39e-05	0.000243	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL2—ovarian cancer	5.39e-05	0.00052	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—ovarian cancer	5.37e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—ovarian cancer	5.37e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK3—ovarian cancer	5.35e-05	0.000517	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—ovarian cancer	5.35e-05	0.000516	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—ovarian cancer	5.35e-05	0.000516	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CAV1—ovarian cancer	5.33e-05	0.000515	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—ovarian cancer	5.29e-05	0.000511	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—ovarian cancer	5.29e-05	0.000511	CbGpPWpGaD
Boceprevir—Asthenia—Epirubicin—ovarian cancer	5.29e-05	0.000239	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	5.29e-05	0.00051	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	5.24e-05	0.000506	CbGpPWpGaD
Boceprevir—Pruritus—Epirubicin—ovarian cancer	5.22e-05	0.000235	CcSEcCtD
Boceprevir—CTSK—Immune System—ERBB2—ovarian cancer	5.2e-05	0.000502	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.17e-05	0.000499	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—ovarian cancer	5.16e-05	0.000498	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	5.15e-05	0.000497	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ESR1—ovarian cancer	5.14e-05	0.000496	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MTOR—ovarian cancer	5.13e-05	0.000495	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CB—ovarian cancer	5.13e-05	0.000495	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK1—ovarian cancer	5.1e-05	0.000492	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—ovarian cancer	5.09e-05	0.000492	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—ovarian cancer	5.08e-05	0.000491	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—ovarian cancer	5.08e-05	0.000491	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—ovarian cancer	5.07e-05	0.00049	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6ST—ovarian cancer	5.05e-05	0.000488	CbGpPWpGaD
Boceprevir—Diarrhoea—Epirubicin—ovarian cancer	5.05e-05	0.000228	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—ovarian cancer	5.03e-05	0.000227	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—HRAS—ovarian cancer	4.97e-05	0.000479	CbGpPWpGaD
Boceprevir—Asthenia—Doxorubicin—ovarian cancer	4.9e-05	0.000221	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—EGFR—ovarian cancer	4.89e-05	0.000472	CbGpPWpGaD
Boceprevir—Dizziness—Epirubicin—ovarian cancer	4.88e-05	0.00022	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PIK3CG—ovarian cancer	4.86e-05	0.000469	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APC—ovarian cancer	4.86e-05	0.000469	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CD—ovarian cancer	4.85e-05	0.000468	CbGpPWpGaD
Boceprevir—Pruritus—Doxorubicin—ovarian cancer	4.83e-05	0.000218	CcSEcCtD
Boceprevir—CTSK—Immune System—CDKN1B—ovarian cancer	4.81e-05	0.000465	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—ovarian cancer	4.81e-05	0.000464	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—ovarian cancer	4.78e-05	0.000462	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—ovarian cancer	4.78e-05	0.000462	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—ovarian cancer	4.77e-05	0.000461	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—ovarian cancer	4.77e-05	0.000461	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—ovarian cancer	4.77e-05	0.00046	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—ovarian cancer	4.75e-05	0.000459	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—ovarian cancer	4.71e-05	0.000455	CbGpPWpGaD
Boceprevir—Vomiting—Epirubicin—ovarian cancer	4.69e-05	0.000212	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—ovarian cancer	4.67e-05	0.000211	CcSEcCtD
Boceprevir—Rash—Epirubicin—ovarian cancer	4.65e-05	0.00021	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—ovarian cancer	4.64e-05	0.00021	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—KRAS—ovarian cancer	4.62e-05	0.000446	CbGpPWpGaD
Boceprevir—Headache—Epirubicin—ovarian cancer	4.62e-05	0.000208	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	4.58e-05	0.000442	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK3—ovarian cancer	4.57e-05	0.000441	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK3—ovarian cancer	4.57e-05	0.000441	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—ovarian cancer	4.55e-05	0.000439	CbGpPWpGaD
Boceprevir—Dizziness—Doxorubicin—ovarian cancer	4.51e-05	0.000204	CcSEcCtD
Boceprevir—CTSK—Immune System—PTEN—ovarian cancer	4.43e-05	0.000428	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—ovarian cancer	4.42e-05	0.000427	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—ovarian cancer	4.39e-05	0.000423	CbGpPWpGaD
Boceprevir—Nausea—Epirubicin—ovarian cancer	4.38e-05	0.000198	CcSEcCtD
Boceprevir—CTSL—Immune System—MAPK1—ovarian cancer	4.35e-05	0.00042	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK1—ovarian cancer	4.35e-05	0.00042	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—ovarian cancer	4.35e-05	0.00042	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—ovarian cancer	4.35e-05	0.00042	CbGpPWpGaD
Boceprevir—Vomiting—Doxorubicin—ovarian cancer	4.34e-05	0.000196	CcSEcCtD
Boceprevir—Rash—Doxorubicin—ovarian cancer	4.3e-05	0.000194	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—ovarian cancer	4.3e-05	0.000194	CcSEcCtD
Boceprevir—CTSS—Immune System—ERBB2—ovarian cancer	4.28e-05	0.000413	CbGpPWpGaD
Boceprevir—Headache—Doxorubicin—ovarian cancer	4.27e-05	0.000193	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PIK3CD—ovarian cancer	4.27e-05	0.000412	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.26e-05	0.000412	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—ovarian cancer	4.25e-05	0.00041	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MTOR—ovarian cancer	4.22e-05	0.000408	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CB—ovarian cancer	4.22e-05	0.000408	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NME2—ovarian cancer	4.22e-05	0.000407	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—ovarian cancer	4.21e-05	0.000406	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.21e-05	0.000406	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—ovarian cancer	4.11e-05	0.000396	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—ovarian cancer	4.11e-05	0.000396	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—ovarian cancer	4.09e-05	0.000395	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.09e-05	0.000395	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—ovarian cancer	4.05e-05	0.000183	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	4e-05	0.000386	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—ovarian cancer	3.96e-05	0.000383	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1B—ovarian cancer	3.96e-05	0.000383	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—ovarian cancer	3.95e-05	0.000382	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—ovarian cancer	3.93e-05	0.000379	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—ovarian cancer	3.92e-05	0.000378	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—ovarian cancer	3.88e-05	0.000374	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK3—ovarian cancer	3.79e-05	0.000366	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	3.78e-05	0.000365	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—ovarian cancer	3.77e-05	0.000364	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—ovarian cancer	3.77e-05	0.000364	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—ovarian cancer	3.77e-05	0.000364	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTNNB1—ovarian cancer	3.75e-05	0.000361	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MTOR—ovarian cancer	3.72e-05	0.000359	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CB—ovarian cancer	3.72e-05	0.000359	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—ovarian cancer	3.65e-05	0.000352	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—ovarian cancer	3.61e-05	0.000349	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK1—ovarian cancer	3.6e-05	0.000348	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYTB—ovarian cancer	3.6e-05	0.000348	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—ovarian cancer	3.6e-05	0.000348	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—ovarian cancer	3.58e-05	0.000345	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1B—ovarian cancer	3.49e-05	0.000337	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—ovarian cancer	3.49e-05	0.000337	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—ovarian cancer	3.49e-05	0.000337	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—ovarian cancer	3.47e-05	0.000335	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—ovarian cancer	3.42e-05	0.00033	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—ovarian cancer	3.42e-05	0.00033	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—ovarian cancer	3.4e-05	0.000328	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	3.37e-05	0.000326	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—ovarian cancer	3.34e-05	0.000323	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—ovarian cancer	3.34e-05	0.000323	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—ovarian cancer	3.33e-05	0.000322	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—ovarian cancer	3.3e-05	0.000318	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—ovarian cancer	3.26e-05	0.000315	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—ovarian cancer	3.26e-05	0.000314	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—ovarian cancer	3.23e-05	0.000312	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—ovarian cancer	3.22e-05	0.00031	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP1CC—ovarian cancer	3.15e-05	0.000304	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BRIP1—ovarian cancer	3.15e-05	0.000304	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—ovarian cancer	3.13e-05	0.000302	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK3—ovarian cancer	3.12e-05	0.000301	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—ovarian cancer	3.08e-05	0.000298	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—ovarian cancer	3.08e-05	0.000298	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK1—ovarian cancer	2.97e-05	0.000286	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—ovarian cancer	2.97e-05	0.000286	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.93e-05	0.000283	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—ovarian cancer	2.9e-05	0.00028	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—ovarian cancer	2.89e-05	0.000279	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—ovarian cancer	2.88e-05	0.000278	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—ovarian cancer	2.87e-05	0.000277	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—ovarian cancer	2.8e-05	0.000271	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—ovarian cancer	2.77e-05	0.000267	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK3—ovarian cancer	2.75e-05	0.000265	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.73e-05	0.000263	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYTB—ovarian cancer	2.72e-05	0.000262	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.72e-05	0.000262	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—ovarian cancer	2.67e-05	0.000258	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.66e-05	0.000257	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.64e-05	0.000254	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK1—ovarian cancer	2.61e-05	0.000252	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—ovarian cancer	2.61e-05	0.000252	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NME2—ovarian cancer	2.6e-05	0.000251	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.59e-05	0.00025	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—ovarian cancer	2.58e-05	0.000249	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.57e-05	0.000248	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—ovarian cancer	2.55e-05	0.000247	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.5e-05	0.000241	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—ovarian cancer	2.47e-05	0.000238	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—ovarian cancer	2.38e-05	0.00023	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP1CC—ovarian cancer	2.38e-05	0.000229	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BRIP1—ovarian cancer	2.38e-05	0.000229	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—ovarian cancer	2.28e-05	0.00022	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—ovarian cancer	2.27e-05	0.000219	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.26e-05	0.000218	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—ovarian cancer	2.19e-05	0.000212	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.14e-05	0.000206	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—YAP1—ovarian cancer	2.11e-05	0.000204	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—ovarian cancer	2.1e-05	0.000203	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—ovarian cancer	2.1e-05	0.000203	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.08e-05	0.000201	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.03e-05	0.000196	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.03e-05	0.000196	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—ovarian cancer	2.01e-05	0.000194	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.92e-05	0.000185	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—ovarian cancer	1.85e-05	0.000179	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.76e-05	0.00017	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FASN—ovarian cancer	1.72e-05	0.000166	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.71e-05	0.000165	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.69e-05	0.000163	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYTB—ovarian cancer	1.68e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.64e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—YAP1—ovarian cancer	1.59e-05	0.000154	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.57e-05	0.000151	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.46e-05	0.000141	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.46e-05	0.000141	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.44e-05	0.000139	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.39e-05	0.000134	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FASN—ovarian cancer	1.3e-05	0.000125	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.29e-05	0.000125	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.28e-05	0.000123	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—ovarian cancer	1.27e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.23e-05	0.000119	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.18e-05	0.000114	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.05e-05	0.000101	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—ovarian cancer	1.02e-05	9.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—YAP1—ovarian cancer	9.82e-06	9.48e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—ovarian cancer	9.57e-06	9.24e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—ovarian cancer	9.31e-06	8.99e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—ovarian cancer	8.19e-06	7.9e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FASN—ovarian cancer	8.01e-06	7.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.88e-06	7.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—ovarian cancer	7.71e-06	7.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.61e-06	7.34e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.29e-06	7.04e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—ovarian cancer	7.13e-06	6.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—ovarian cancer	7.03e-06	6.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.47e-06	6.24e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—ovarian cancer	6.18e-06	5.96e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—ovarian cancer	6.17e-06	5.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.01e-06	5.8e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—ovarian cancer	5.9e-06	5.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—ovarian cancer	5.38e-06	5.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—ovarian cancer	4.75e-06	4.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—ovarian cancer	4.65e-06	4.49e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—ovarian cancer	4.35e-06	4.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.33e-06	4.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.81e-06	3.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—ovarian cancer	3.55e-06	3.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.32e-06	3.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—ovarian cancer	3.28e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—ovarian cancer	2.87e-06	2.77e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—ovarian cancer	2.68e-06	2.59e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.02e-06	1.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—ovarian cancer	1.65e-06	1.59e-05	CbGpPWpGaD
